Skip to content
Open access

Parsing the Functional Heterogeneity of the Psychosis Spectrum: A Clinically Informed Application of Genomic Structural Equation Modeling

Sep 2026 · medRxiv · 0 citations · 93 references
Medicine

TL;DR

It is demonstrated that a clinically informed genomic model can shed light on the functional heterogeneity of psychosis, identify both unique and shared biological components and highlight its partial neurodevelopmental origin.

Abstract

Schizophrenia, bipolar disorder, and major depression vary in their age of onset, cognitive impacts, degree of impairment, and clinical course. However, since psychosis is a transdiagnostic feature that occurs across all three of these disorders, they can be represented as a spectrum. We leveraged genomic data to explore different functionally distinct components of the psychosis spectrum. We used Genomic Structural Equation Modelling (Genomic SEM) to define four factors indexing specific aspects of psychosis-related symptoms shared across depression, schizophrenia, and bipolar disorder: a general Psychosis factor with low Cognitive functionality (gPsychosisCognition), a specific Psychosis factor independent of cognition (sPsychosis), a specific Affective factor independent of psychosis (sAffective) and a specific Mania factor independent of depression (sMania). We then used Stratified Genomic SEM and transcriptomic analyses to characterize biological functions and temporal trends associated with these factors. sPsychosis, sAffective, and sMania exhibited differential genetic correlations with personality, with sPsychosis and sAffective showing positive correlations with Openness, while Neuroticism showed a strong positive correlation with sAffective and a negative correlation for sMania. GABAergic, cortical, and CA1-CA3 enrichments were significant across the continuum with evidence for factor specific enrichment: dentate gyrus, CA4 and cerebellum were non-significant only for sAffective and oligodendrocytes enriched only in gPsychosisCognition. Transcriptomic analyses revealed different temporal expression trends across factors, identifying a mostly prenatal expression for sMania and sAffective, and more consistent expression across development for sPsychosis. We demonstrated that a clinically informed genomic model can shed light on the functional heterogeneity of psychosis, identify both unique and shared biological components and highlight its partial neurodevelopmental origin.

Read PDF

Similar papers

Open access Oct 2026

Latent Brain-Symptom Dimensions Characterize Heterogeneity in Clinical High Risk for Psychosis

BACKGROUND: Clinical high risk (CHR) for psychosis is characterized by substantial heterogeneity in symptoms, functioning, and outcomes. Although distributed resting-state functional connectivity (RSFC) abnormalities have been reported, it remains unclear whether this heterogeneity can be organized into consistent mult...

J. Feng, S. Genon, S. Eickhoff et al. · 0 citations
Oct 2026

Beyond diagnostic boundaries: Evaluating neurocognitive and biomarker profiles in the psychosis spectrum based on Schneiderian first-rank symptoms.

BACKGROUND This study aimed to evaluate the neurobiological overlap and divergence between schizophrenia (SZ) and bipolar disorder (BD) subtypes. Specifically, we investigated neurotrophic factors, inflammatory markers, and cognitive functions by categorizing patients based on a lifetime history of Schneiderian first-r...

Tugay Elik, E. Öztürk, A. Cinkara et al. · 0 citations
Open access Aug 2026

Genomic dimensions deconstruct the clinical heterogeneity of bipolar disorder

Bipolar disorder’s genetic architecture appears hierarchical—a general liability resolving into dimensions of course and comorbidity, beyond subtypes, beyond subtypes.

Tracey van der Veen, M. Tesfaye, J. M. K. Yang et al. · 0 citations
Review Open access Aug 2026

Mapping the Heterogeneity of Major Depressive Disorder: A Systematic Review of Multi-Omics Integration Studies

Results indicate that multi-omics integration, in addition to explaining the molecular architecture of MDD, also characterizes patient subgroups with pathophysiological mechanisms, dimensions of symptoms, and disease treatment, which demonstrates that there is a shift in psychiatry toward a more mechanistic approach.

Elham Amjad, B. Sokouti · 0 citations
Open access Aug 2026

Growth factor receptor profiles across schizophrenia spectrum disorders: associations with disease stage and clinical course

Schizophrenia is a chronic psychiatric disorder that significantly impairs quality of life. Its causes are complex, involving genetic predisposition, environmental factors, neurodevelopmental issues, chronic inflammation, and neurotransmitter disturbances. As diagnosis is primarily symptom-based, there is growing i...

Elżbieta Cecerska-Heryć, Paula Bekasz, Aleksandra Polikowska et al. · 0 citations
Open access Oct 2026

Genetic risk of psychopathology predicts environmental risk

Environmental risk factors for psychosis and psychopathology are often treated as non-genetic, although many are partly heritable or correlated with genetically influenced traits. We tested nine polygenic scores against 49 environmental-risk factors in 307,493 UK Biobank participants without recorded schizophrenia, b...

Adam Socrates, Jessie R. Baldwin, Robin M. Murray et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.